← The Wire
BIOANasdaq
BioAge Labs, Inc.
Pharmaceutical Preparations · DE · CIK 1709941
Developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging
$802M
Market cap
$24.95
Last close
+5.0%
1D
+16.2%
5D
769K
Volume
Price · last 39 sessions+50.1%
May 4L $15.34 · H $24.95Jun 29
37
Total filings
Jun 12, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 12, 20268-KResults of OperationsMay 8, 202610-Q10-QMay 8, 2026DEFA14ADEFA14AApr 21, 2026DEF 14ADEF 14AApr 21, 202610-K10-KMar 24, 20268-KResults of Operations · Reg FD DisclosureMar 24, 20268-KMaterial Agreement · Reg FD DisclosureJan 22, 2026424B5424B5Jan 22, 2026424B5424B5Jan 20, 20268-KReg FD Disclosure · Company UpdateJan 20, 20268-KReg FD Disclosure · Company UpdateJan 12, 20268-KReg FD Disclosure · Company UpdateDec 4, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 6, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KShareholder VoteJun 9, 20258-KCompany UpdateJun 4, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 17, 2025DEF 14ADEF 14AApr 17, 202510-K10-KMar 20, 20258-KResults of OperationsMar 20, 2025SC 13GSC 13GNov 14, 2024SC 13GSC 13GNov 12, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 2024SC 13GSC 13GOct 7, 2024SC 13DSC 13DOct 4, 2024SC 13DSC 13DSep 30, 20248-KMaterial Agreement · Equity IssuanceSep 27, 2024424B4424B4Sep 26, 2024S-1/AS-1/ASep 25, 2024S-1/AS-1/ASep 18, 2024S-1S-1Sep 3, 2024
Insider Activity
In the 90 days to Mar 2, 2026: 3 sold $6.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Rubin Paul DChief Medical Officer | Sell | 7,433 | $20.30 | $151K |
| Feb 2, 2026 | Rubin Paul DChief Medical Officer | Sell | 7,433 | $18.75 | $139K |
| Jan 13, 2026 | Fortney KristenChief Executive Officer | Sell | 233,107 | $18.12 | $4.2M |
| Jan 13, 2026 | Goldstein Dov A MdChief Financial Officer | Sell | 11,663 | $20.54 | $240K |
| Jan 13, 2026 | Goldstein Dov A MdChief Financial Officer | Sell | 8,974 | $18.43 | $165K |
| Jan 13, 2026 | Goldstein Dov A MdChief Financial Officer | Sell | 4,440 | $19.45 | $86K |
| Jan 13, 2026 | Goldstein Dov A MdChief Financial Officer | Sell | 1,923 | $21.08 | $41K |
| Jan 2, 2026 | Rubin Paul DChief Medical Officer | Sell | 7,433 | $12.85 | $96K |
| Dec 9, 2025 | Rubin Paul DChief Medical Officer | Sell | 18,000 | $12.00 | $216K |
| Dec 4, 2025 | Rubin Paul DChief Medical Officer | Sell | 68,897 | $10.19 | $702K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance